|
|
||||||||
Washington University School of Medicine, St. Louis, Missouri
Correspondence: For reprints contact: Dr. Dov Kadmon, Washington Univ. Med. School, Div. of Urol., 4960 Audubon Ave., St. Louis, MO 63110.
ABSTRACT
We studied the effect of alpha-difluoromethylornithine (DFMO), an irreversible inhibitor of ornithine decarboxylase, on putrescine uptake by the rat prostate. Using C-14 putrescine, we found a several-fold increase in uptake by both the dorsal and ventral prostates of DFMO-pretreated intact animals, compared with untreated controls. When previously castrated animals were treated with a combination of testosterone and DFMO, the prostatic uptake of exogenously administered C-14 putrescine increased more than tenfold. Under these condition, DFMO enhanced the uptake by the prostate to a greater extent than by any other tissue studied.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |